Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main Vera Therapeutics, Inc. Transaction History
Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main
- $91.1 Billion
- Q4 2024
A detailed history of Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main holds 10,182 shares of VERA stock, worth $291,001. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,182Holding current value
$291,001% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding VERA
# of Institutions
193Shares Held
63.9MCall Options Held
68.1KPut Options Held
88.6K-
Avoro Capital Advisors LLC New York, NY5.61MShares$160 Million3.46% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.38MShares$125 Million0.02% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$95.4 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$84.6 Million19.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.95MShares$84.3 Million0.0% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $773M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...